← Back to Search

Behavioral Intervention

ACT Self-help Workbook for Depression and Anxiety

Madison, WI
N/A
Recruiting
Led By Michael Koenigs, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Moderate or severe anxiety and/or depression determined by the Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI)
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study duration, up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to test a self-help workbook in prisons to see if it is helpful. Participants will be involved in the study for 13 weeks."

See full description
Who is the study for?
This trial is for adults in prison with moderate to severe anxiety or depression, who can read at a 6th-grade level or higher and have no plans of transfer or release within three months. Participants must not be actively self-harming or suicidal.Check my eligibility
What is being tested?
The study tests an Acceptance and Commitment Therapy (ACT) workbook adapted for prisoners against Cognitive Behavioral Therapy (CBT). It aims to see how feasible, acceptable, and effective the ACT approach is over a period of 13 weeks.See study design
What are the potential side effects?
Since this trial involves psychological therapies rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort while confronting difficult thoughts and feelings during therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have moderate to severe anxiety or depression according to the BDI-II and BAI tests.
 show original
Select...
I am 18 years old or older.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study duration, up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and study duration, up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change BDI-II Score
Change in BAI Score
Change in Mental Health: Automatic Thoughts
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ACT workbookExperimental Treatment1 Intervention
Group II: Control workbookActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acceptance and Commitment Therapy (ACT)
2016
Completed Phase 4
~2480

Find a Location

Closest Location:University of Wisconsin· Madison, WI

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
3,004 Previous Clinical Trials
2,852,056 Total Patients Enrolled
University of Wisconsin, MadisonLead Sponsor
1,248 Previous Clinical Trials
3,255,055 Total Patients Enrolled
Michael Koenigs, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
130 Total Patients Enrolled
~64 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top